UCB - Current Liabilities

Stock Price
239.00
Daily Change
-7.30 -2.96%
Monthly
-5.87%
Yearly
59.65%
Q2 Forecast
258.33

UCB reported EUR4.4B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Alcon AG USD 3.05B 59M Dec/2025
Almirall EUR 350.64M 52.12M Dec/2025
Amarin USD 194.46M 12.23M Dec/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Galapagos EUR 152.86M 213.7M Dec/2025
Genmab DKK 1.43B 686M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Orion EUR 798.6M 238.3M Mar/2026
Recordati EUR 1.04B 24.44M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
UCB EUR 4.4B 470M Dec/2025
Unibail Rodamco EUR 3.13B 2.32B Dec/2025